BECN1 and cancer: There was no significant association between the percent cancer cell staining for Beclin 1, ATG7, and CD68 or the percentage change for HMGB1 and LC3‐II with the CA19‐9 level change, histopathologic tumor response, and other pathologic tumor characteristics.